Geometry.Net - Health_Conditions: Nil Disease


Home - Health_Conditions - Nil Disease

e99.com Bookstore

Images

Newsgroups

41-60 of 84 Back | 1 | 2 | 3 | 4 | 5 | Next 20

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nil Disease: more books (34)

Lichens on Douglas fir trees by Nils Edin, 1941

Bronchogenic carcinoma;: A follow-up study of a surgically treated series with special reference to the prognostic significance of lymph node metastases, (Acta chirurgica Scandinavica) by Nils P Bergh, 1965

20-year review of health work on Hawaiian sugar plantations by Nils Paul Larsen, 1954

Dental decay as an indicator of a dictary fault, by Nils Paul Larsen, 1934

AIDS Two: AIDS in the Workplace by James Vculek, 1989-06

lists with details

LUMI-NIL-MBL
Luminil MBL can also be used to treat luminous bacterial disease inhatcheries and ponds. Lumi-nil MBL can be used to treat postlarvae
http://www.tropicalbiomarine.com/TBMS_Product_LUMINILMBL.html

Extractions: Novel eco-friendly technology Luminous bacterial disease is one of the greatest problems in shrimp hatcheries and farms. The causative agent is Vibrio harveyi which is a common inhabitant of coastal seawaters. These bacteria thrive in association with crustaceans. In shrimp hatcheries, often there are mass mortalities associated with luminous bacteria. The affected animals show luminescence. Even in shrimp grow out systems, luminous bacteria cause serious mortalities and luminous bacterial disease is emerging as a major disease problem in most shrimp growing countries. Antibiotics and chemicals have been found to be ineffective in controlling the problems due to luminous bacteria and in hatcheries, where antibiotics are used regularly, luminous bacteria have been observed to develop resistance. These bacteria can persist in hatchery environment by forming biofilms on various surfaces such as the tank surface, pipes etc. Biofilm bacteria are over 100 times more resistant to sanitisers and antibiotics compared to normal planktonic bacteria. Bacteriophages are viruses affecting only bacteria. They are highly specific in that particular bacteriophage will use only one bacterial species as host. They are inert outside the bacterial cell, but when they come in contact with their host, arrest the normal physiology of the host and utilize the host biochemical machinery for their own replication. After replication inside the host cell, killing it and releasing themselves. Bacteriophages are abundant in aquatic environment and there are different aquatic bacteria. It is thought that bacteriophages play a major role in maintaining a balance of bacterial population in nature.
AllAllergy.Net - Celiac Disease / Sprue / Gluten Related Articles
industry. Discussion of Food Allergy, Food Intolerance, Food Aversion,Lactose Intolerance and Coeliac disease. nil. Your comments,
http://allallergy.net/articles/index.cfm/cdeoc/FR/entered/z/rview/z/whom/z/tingr
AllAllergy.Net - Celiac Disease / Sprue / Gluten Related Articles
This list was created by the Celiac disease OnLine Support Group members. Thislist was compiled from gf food lists posted on our forum message board. nil.
http://allallergy.net/articles/index.cfm/cdeoc/FR/entered/z/rview/z/whom/z/tingr
The Clash Of Civilizations - Disease Model
Effect Disaster. Flood. 13%. 1-5%. Level x 1-15 sqs. adjacent. nil. nil. Fire.1-4%. 1-3%. 1. nil. nil. Drought. N/A. 1-10%. Level x 1-15 sqs. adjacent. 1-2%.Fire. Hurricane.
http://clash.apolyton.net/models/Model-Disasters.shtml

Extractions: Tropical (4,5) Most disasters will be stand-alone events. Some, however, like droughts and hurricanes may cause other disasters to happen. Ill refer to these as Cause and Effect disasters. There is a percentage chance for effect disasters to be triggered by the cause disaster (% Chance to Trigger). There will be different levels of disaster (from 1 to 10), generated for each disaster that occurs. For cause and effect disasters, the level of the effect disaster will be the same as the causing disaster. Other models will determine the exact level for any given disaster. The map model will determine earthquake and volcano levels, while the climate/ecology model will determine flood, drought, and hurricane levels. The difference between the level of infrastructure needed and the level of current infrastructure will determine fire levels.
Peanuts - Disease Management
Do not use Alto if net blotch is present or expected. After two weeks, spray againif disease conditions continue or wait until the next infection period. nil.
http://www.dpi.qld.gov.au/fieldcrops/8076.html

Extractions: Access keys Skip to primary navigation Skip to secondary navigation Skip to content ... Printer-friendly Search: Industries Key activities Services The Department ... News FAQs The serious foliage diseases of peanuts are leafspot ( Cercospora arachidicola and Cercosporidium personatum ), rust ( Puccinia arachidis ) and net blotch ( Didymosphaeria arachidicola ). They spread during wet weather, dew and irrigation. It takes about seven to 10 days after infection before diseases can be seen. Note that peanuts can tolerate a low level of infection before any yield is lost. Leaf (or foliar) diseases are a serious problem in Central and North Queensland. If dark spots or marks are found, seek advice before spraying. It may not be a disease. All of the diseases described below can be controlled with fungicides. Under irrigation, at least two to four fungicide sprays should be budgeted for at a cost of about $40/ha/spray. The number of sprays will be higher as leaf diseases become established in the area. Leafspot fungi cause dark brown to black spots on the leaves and these will first show on the oldest leaves. The fungi will survive on peanut stubble so peanuts following peanuts will be infected earlier than peanuts after another summer crop.
Dizdar, Nil, Microdialysis As A Tool In Studies Of L-Dopa And Metabolites In Mal
588. Microdialysis as a Tool in Studies of LDopa and Metabolites in MalignantMelanoma and Parkinson's disease. nil Dizdar. Akademisk avhandling.
http://www.bibl.liu.se/liupubl/disp/disp99/Med588s.htm

Extractions: No. 588 Microdialysis as a Tool in Studies of L-Dopa and Metabolites in Malignant Melanoma and Parkinson's Disease Nil Dizdar Akademisk avhandling Fakultetsopponent: Docent Christer Hansson, Inst. for Dermatologi och Venereologi, Lund. Abstract A model with human melanoma xenografts transplanted to athymic mice has been adopted for in vivo studies of 5-S-cysteinyldopa (an intermediate pigment metabolite), glutathione, and cysteine. L-Dopa is an intermediate metabolite in pigment formation and is also important in the treatment of Parkinson's disease, and therefore 1 have also studied the pharmacokinetics of this compound. We were first to describe in vivo microdialysis in melanoma tissue and showed that dialysis membranes of cuprophane or polyamide are suitable for studies of interstitial 5-S-cysteinyldopa and selected thiols. Analytical procedures were also improved for quantitation of 5-S-cysteinyldopa, L-dopa, glutathione, cysteine, and N-acetylcysteine (NAC). In the melanoma xenografts the interstitial concentration of 5-S-cysteinyldopa reflected the high intracellular production of this intermediate metabolite. For in vivo manipulation of glutathione in the melanoma tissue we gave intraperitoneal injection of buthionine sulphoximine to the animals and thus reduced the glutathione concentrations substantially. We showed that restitution of glutathione in melanoma tissue occurs spontaneously and is not much improved by treatment with the cysteine deliverers NAC and L-2-oxothiazolidine-4-carboxylate (OTC). 5-S-Cysteinyldopa was not substantially affected by great variations in glutathione concentrations. Transport of NAC from intraperitoneal injection to melanoma tissue occurred rapidly and deacetylation to cysteine
GRDC - Research Updates - Managing Bean Disease (2002)
For time of sowing two (19 June), the trend in yield from nil fungicides from to fungicideapplications, and delays in sowing reduce the losses due to disease.
http://www.grdc.com.au/growers/res_upd/hirain/02/narac_beandisease.htm

Extractions: Title Managing bean disease Description Research Update - Southern Region - Spring 2002 Key Words fungicide trials, Fiesta, Fiord, Manafest GRDC Code* DAS 280, UA 417, MFM 1 Author Wayne Hawthorne, Field Crop Evaluation, SARDI, Struan, SA Presented Naracoorte, SA *Note - this report may contain independently supported projects, which complement the work in this GRDC research program. Trials reported here contributed to comprehensive bean disease management advice written in the pamphlet "Faba bean disease management strategy for Southern Region GRDC 2002". In several fungicide trials around the state, Fiesta responded to fungicide applications, but the response was less than in Fiord and in some other years. Fungicide timing is important. Where fungicide products were assessed, carbendazim appeared to be only slightly better than mancozeb for chocolate spot, but not always. In variety trials, Fiesta had a good year in 2001, but so too did Fiord. Manafest had a poor one because of severe ascochyta, but we can improve our management with it. FIESTA (2001 yield 3.78 t/ha = 100%, range 1.90 t/ha to 5.15 t/ha: long term 1992-2000 average = 2.53 t/ha). Relative to the site mean, the best site for Fiesta was in the Mid South-East at a site where ascochyta and lodging was severe. The worst sites for Fiesta relative to the site mean were on Upper Eyre Peninsula, Mid North and the Lower South-east Lodging at some sites and ascochyta at others were the major issues with Fiesta in 2001.
GRDC - High Grains Issue 11 - Disease Management For High-rainfall Wheat
disease, Pathogen, Potential, Control options, Public risk. Takeall, Gaeumannomycesgraminis var. tritici, high, rotation (1 year), winter cleaning, no, yes, yes,nil.
http://www.grdc.com.au/growers/hg/11/disease.htm

Extractions: Issue 11, Winter 2002 A list of potential diseases, control options and risks for higher altitude, high-rainfall areas of NSW is supporting better crop management and improved yields. The list is an improved, updated version of one that appeared in High Grains 3 in 1998. (While relating specifically to the NSW tablelands, the list can readily form the basis for diseases in other high-rainfall, long-season areas in the south-east.) The list has been refined with data from: Appropriate management for these diseases should consider variety selection, paddock selection and preparation, and treatment of seed with a registered seed dressing. Sow varieties with the following disease resistances: essential - stem rust, stripe rust, leaf rust
Tests
infection or loosening, Paget's disease, avascular necrosis, Reflex Sympathetic Dystrophy,HPOA, metabolic bone disease. Preparation nil (bring available Xrays
http://wwwsvh.stvincents.com.au/nucmed/test_table.html

Extractions: Test Indications Preparation: Time BONE Investigation of tumours (primary and secondary), arthritis, musculoskeletal pain, fractures, sports injuries, osteomyelitis, prosthesis infection or loosening, Paget's disease, avascular necrosis, Reflex Sympathetic Dystrophy, HPOA, metabolic bone disease. Preparation: Nil (bring available Xrays) Time: 4 hours 2nd part 1 hour 1. MYOCARDIAL PERFUSION SCAN (SESTAMIBI) Diagnosis/management/prognosis of ischaemic heart disease and cardiomyopathy. Viability assessment. Preparation: Fast minium 4 hours, (water allowed), adjust medications Time: up to 5 hours 2. GATED BLOOD POOL STUDY Left and right ventricular size and function (ejection fraction, wall motion). Preparation: Nil Time: 1 1/2 hours BONE DENSITOMETRY AND BODY COMPOSITION 1. Quantitative assessment of bone mineral density in investigation and management of osteoporosis.
Alliance Resource Inventory: List By Disease
Support Groups, N, P, T, O, A, S. P. Adults/Both, 2, 3. Community, Other, Yes,No Training Required, nil. Click to return to the top of this page.Heart disease.
http://www.preventionalliance.mb.ca/inventory/list-dis.html

Extractions: Organization Program Title Risk Factor Objective Target Age/Gender Prevention Level Site Application Format Evaluated? Training Cost Manitoba Lung Association Asthma in the Schools - Epi-Pen Use K, S. Professional/Both School Print and Video Yes Instructor Supplied Varies Manitoba Lung Association Asthma Presentations (for Communities) K, S. Any Age/Both Community Print and Video No Instructor Supplied Mileage re-imbursement Manitoba Lung Association Asthma Trec K, S, P. Professional/Both Health Facility Other Yes Training Required $650 registration fee Organization Program Title Risk Factor Objective Target Age/Gender Prevention Level Site Application Format Evaluated? Training Cost CancerCare Manitoba Blood and Marrow Transplant Program P. Any Age/Both Health Facility Other No Training Required Nil CancerCare Manitoba Breast Cancer Centre of Hope K, P.
Guilford Pharmaceuticals
On July 26, 2001, Guilford announced that Amgen had completed the PhaseII clinical trial of nilA in patients with Parkinsons disease.
http://www.guilfordpharm.com/media/backgrounders/neuroligands.html
Guilford Pharmaceuticals
On July 26, 2001 Guilford announced the completion of the nilA PhaseII clinical trial for Parkinson's disease. The results suggested
http://www.guilfordpharm.com/products/marketed/neuroligands.html
A Meta-analysis Of Residual Disease And Survival In Stage III And IV Carcinoma O
RESULTS The results show a survival benefit for patients with nil and = 2 cm residualdisease after surgery for both stage III and IV disease when compared
http://www.slip.net/~mcdavis/dbas9697/96076301.htm

Extractions: Universal Identifier Title A meta-analysis of residual disease and survival in stage III and IV carcinoma of the ovary. Author - Allen DG; Heintz AP; Touw FW Address - Mercy Hospital for Women, East Melbourne, Australia. Source - Eur J Gynaecol Oncol 1995;16(5):349-56 Abstract Home Page Mission What's New Search ... Anti-Angiogenesis
Alice Bailey & Djwhal Khul - Esoteric Healing - The Training Of The Healer
The responsibility of a child for his living conditions is practically nil, unlessyou I would only suggest here that the whole subject of disease could be
http://beaskund.helloyou.ws/netnews/bk/healing/heal1006.html

Extractions: To Netnews Homepage Previous Next Index ... Table of Contents Esoteric Healing - The Basic Causes of Disease The Training of the Healer As regards the training of the healer, I will give from time to time the six rules which govern (or should govern) his activity. Bear in mind the two words which I earlier gave. They sum up the healer's story: Magnetism and Radiation . They are different in their effects as we shall later see. Rule one The healer must seek to link his soul, his brain, his heart and auric emanation. Thus can his presence feed the [18] soul life of the patient. This is the work of radiation. The hands are needed not. The soul displays its power. The patient's soul responds through the response of his aura to the radiation of the healer's aura, flooded with soul energy. In considering the Causes of Disease, I find it necessary to speak a word in connection with conditions - external and internal. It will be apparent to the casual thinker that many diseases and many causes of death are due to environing conditions for which he is in no way responsible. These range all the way from purely external occurrences to hereditary predispositions. They might be listed as follows:
Alice Bailey & Djwhal Khul - Esoteric Healing - IX - The Seven Healing Technique
that the Black Lodge initiates likewise heal or produce death and disease, andemploy man is concerned, the danger of black interference is nil; the dark
http://beaskund.helloyou.ws/netnews/bk/healing/heal1255.html

Extractions: To Netnews Homepage Previous Next Index ... Table of Contents Esoteric Healing - Chapter IX - The Seven Modes of Healing III. The Seven Healing Techniques The techniques I shall have to give in the form of seven ancient symbolic statements or formulas, gathered out of the Book of Rules for Initiated Disciples. I dare not yet give the simple physical application of these ray techniques, as it would be too dangerous. When rightly used and understood they carry terrific force and - in the wrong hands - could work real damage. May I remind you here that the Black Lodge initiates likewise heal or produce death and disease, and employ very similar techniques; the difference lies in the fact that they can work only with the personality rays of both healer and patient, and because they are more potent on the physical plane than are the Members of the Great White Lodge, their work is frequently most effective. The spiritual healer, working with the energies of light whenever possible, is seldom as effective physically. Some disciple in the early part of next century will take these techniques or magical statements, relating to the healing work, and interpret them and elucidate them. They are susceptible of three significances, the lowest of which the modern student may succeed in interpreting for himself if he reflects adequately and lives spiritually. Here are the seven statements.
The Pathology Guy -- Online Help
Amyloidosis. Minimal change ( nil ) disease ( lipoid nephrosis ). Focalsegmentalglomerulosclerosis. Wegener's granulomatosis. Small-vessel polyarteritis.
http://www.pathguy.com/lectures.htm

Extractions: Verify here. Interested in an obscure disease? Obviously, I cannot be your doctor, cannot substitute for a physician of your own, and cannot diagnose or treat over the 'web. Whether you are a medical student seeking a study guide, or a sick person seeking answers, you must understand that these notes, and any correspondence we may have, are provided for informational purposes only, and with the understanding that I am not engaged in rendering medical or professional services. If you, or someone special to you, is sick, you need to review all information carefully with your health care provider. No physician can know everything. However, I'm honest and interested in being useful. And if there's something you need to know, I can probably help you find it. E-mail me at erf@uhs.edu and let me know how I can help. This is completely confidential. If you are still looking for information, and you are in the U.S., I suggest you use a Medline search from
Chapter DE MORTUIS NIL NISI BONUM to DEATH Of Index By Grocott's Quotatio
As man, perhaps, the moment of his breath, Receives the lurking principle of death;The young disease, that must subdue at length, Grows with his growth, and
http://www.bibliomania.com/2/3/265/1541/21713/3.html
Crop Updates 1998 : Cereals : Department Of Agriculture
nil, 290 mL at Z39+Z65, 2.93, 2.0, 74.3, 41.4. P value, 0.001, 0.001, 0.001, 0.001. LSD (0.05), 0.20, 0.37, 0.64, 2.26. Relationship between disease andyield.
http://www.agric.wa.gov.au/cropupdates/1998/cereals/leaf.htm

Extractions: Plant Pathology, Agriculture Western Australia, South Perth The relationship between disease and yield was examined in an experiment at Mingenew to help understand the effect of disease on yield and to examine the ability to predict late season disease severity from assessments made at the time of flag leaf emergence (the most appropriate time for fungicide application). Total disease was highly negatively correlated with yield. Disease development after flag leaf emergence was most critical for yield because disease did not differ at early assessments (Z31 and Z39). Disease assessed at flag leaf emergence was not a good predictor of later disease severity in this experiment. However, indications are that the level of disease observed at flag leaf emergence may not need to be very high to result in significant and economic yield responses. Yellow spot and septoria nodorum blotch are major constraints to wheat production in higher rainfall areas of northern wheatbelt. The impact of these diseases varies, but yield losses recorded range from zero to 62% in Western Australia. An experiment was conducted to examining yield loss under different rates of disease progress in wheat resulting from different initial disease levels and fungicide use. The results will help in deciding when the use of fungicide will result in an economical yield response and thus increase the confidence of growers in chemical control of the disease.
Guilford Pharmaceuticals, 1998 Annual Report
Initially developed for the treatment of Parkinsons disease, nilA is part ofa second generation of neuroimmunophilin compounds developed by Guilford and
http://media.corporate-ir.net/media_files/nsd/glfd/reports/ar98/regen.htm

Extractions: These are magnified images of nerve cells which have been treated with one of our neuroimmunophilin compounds. You can see that as the dose increases, so do the number of nerve processes. The production of these processes is the first step in nerve regeneration and is essential for normal nerve function. Through the effective application of cutting-edge technologies and a commitment to excellence, Guilford and Amgen stand at the threshold of an important breakthrough. With no drugs yet available which can change the course of most serious neurological disorders, our neuroimmunophilin program offers an exciting blueprint of what is yet to come.
Nil Dizdar: Microdialysis As A Tool In Studies Of L-Dopa And Metabolites In Mali
nil Dizdar, Microdialysis as a Tool in Studies of LDopa and Metabolites in MalignantMelanoma and Parkinsons disease. Date of defense 1999-04-09. Abstract.
http://www.ep.liu.se/diss/med/05/88/

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

41-60 of 84 Back | 1 | 2 | 3 | 4 | 5 | Next 20